DE69117974T2 - Pharmazeutische zusammensetzungen zur behandlung von b-zell-entartungen - Google Patents

Pharmazeutische zusammensetzungen zur behandlung von b-zell-entartungen

Info

Publication number
DE69117974T2
DE69117974T2 DE69117974T DE69117974T DE69117974T2 DE 69117974 T2 DE69117974 T2 DE 69117974T2 DE 69117974 T DE69117974 T DE 69117974T DE 69117974 T DE69117974 T DE 69117974T DE 69117974 T2 DE69117974 T2 DE 69117974T2
Authority
DE
Germany
Prior art keywords
treating
pharmaceutical compositions
cell degeneration
cell malignancies
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69117974T
Other languages
German (de)
English (en)
Other versions
DE69117974D1 (de
Inventor
Jacques Banchereau
France Thierry De
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Schering Plough SAS
Original Assignee
Schering Plough SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Plough SAS filed Critical Schering Plough SAS
Publication of DE69117974D1 publication Critical patent/DE69117974D1/de
Application granted granted Critical
Publication of DE69117974T2 publication Critical patent/DE69117974T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2026—IL-4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69117974T 1990-12-13 1991-12-10 Pharmazeutische zusammensetzungen zur behandlung von b-zell-entartungen Expired - Fee Related DE69117974T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP90403585A EP0490006B1 (fr) 1990-12-13 1990-12-13 Compositions pharmaceutiques pour le traitement de maladies malignes de cellules-B
PCT/EP1991/002380 WO1992010201A1 (fr) 1990-12-13 1991-12-10 Compositions pharmaceutiques destinees au traitement des affections malignes a lymphocytes b

Publications (2)

Publication Number Publication Date
DE69117974D1 DE69117974D1 (de) 1996-04-18
DE69117974T2 true DE69117974T2 (de) 1996-07-25

Family

ID=8205785

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69117974T Expired - Fee Related DE69117974T2 (de) 1990-12-13 1991-12-10 Pharmazeutische zusammensetzungen zur behandlung von b-zell-entartungen

Country Status (16)

Country Link
EP (2) EP0490006B1 (fr)
JP (1) JPH06504767A (fr)
AT (1) ATE135232T1 (fr)
AU (1) AU9072191A (fr)
CA (1) CA2098509A1 (fr)
CZ (1) CZ113593A3 (fr)
DE (1) DE69117974T2 (fr)
DK (1) DK0561927T3 (fr)
ES (1) ES2084995T3 (fr)
FI (1) FI932650A0 (fr)
GR (1) GR3019699T3 (fr)
HU (1) HU210009B (fr)
IE (1) IE64157B1 (fr)
OA (1) OA09788A (fr)
SK (1) SK59193A3 (fr)
WO (1) WO1992010201A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5700461A (en) * 1992-08-19 1997-12-23 Schering Corporation Method for inhibiting HIV replication using IL-4
US5679338A (en) * 1994-05-12 1997-10-21 Osteoarthritis Science, Inc. Use of IL-4 for inhibition of the breakdown of articular cartilage and other tissues
US5716612A (en) * 1994-09-07 1998-02-10 Schering Corporation Use of IL-4 for potentiation of chemotherapeutic agents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU661979B2 (en) * 1990-09-06 1995-08-17 Schering Corporation Use of IL-4 to treat solid tumors

Also Published As

Publication number Publication date
IE914328A1 (en) 1992-06-17
DE69117974D1 (de) 1996-04-18
HU9301719D0 (en) 1993-09-28
OA09788A (en) 1994-04-15
ATE135232T1 (de) 1996-03-15
IE64157B1 (en) 1995-07-12
CA2098509A1 (fr) 1992-06-14
EP0490006A1 (fr) 1992-06-17
DK0561927T3 (da) 1996-07-29
AU9072191A (en) 1992-07-08
WO1992010201A1 (fr) 1992-06-25
FI932650A (fi) 1993-06-10
SK59193A3 (en) 1994-01-12
ES2084995T3 (es) 1996-05-16
EP0490006B1 (fr) 1994-06-22
GR3019699T3 (en) 1996-07-31
EP0561927B1 (fr) 1996-03-13
JPH06504767A (ja) 1994-06-02
CZ113593A3 (en) 1994-01-19
EP0561927A1 (fr) 1993-09-29
FI932650A0 (fi) 1993-06-10
HUT64478A (en) 1994-01-28
HU210009B (en) 1995-01-30

Similar Documents

Publication Publication Date Title
AU2118488A (en) Improvements in or relating to methods of treating damaged skin
DE3684190D1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
DE69100364D1 (de) Verwendung von N-Myristoyl-(S)-Phenylalanin zur Herstellung eines Medikaments zur Behandlung von Krankheiten mittels Hemmung der Myristoylierung.
ES2051641A1 (es) Procedimientos para la preparacion de compuestos derivados de tiourea.
GR3022321T3 (en) Use of il-4 to treat solid tumors
ATE124681T1 (de) Arzneimittelzusammensetzungen zur behandlung von psoriasis.
FI934680A (fi) Arylmorfolin, framstaellning och anvaending
EP0594795A4 (fr) Michellamines utiles comme agents antiviraux, composition et procede de traitement.
DE69117974T2 (de) Pharmazeutische zusammensetzungen zur behandlung von b-zell-entartungen
FI810380L (fi) Fenylpiperazinderivat av 1,3,4-oxadiazolylfenoler deras framstaellning och dessa innehaollande terapeutiska aemnen
DK149590C (da) Analogifremgangsmaade til fremstilling af 2-aryl-3,4-diaza-bicyclo(4,1,0)hepten-(2)-on-(5)-forbindelser
ATE82850T1 (de) Verwendung von 2-pyrimidinyl-1-piperazinderivaten.
DK0420798T3 (da) Antimikrobielle præparater
ATE306278T1 (de) Behandlung von knochenleiden mit adrenomedullin
SE8106190L (sv) Addukter av 1,8-dihydroxi-9-antron, forfarande for framstellning derav och anvendning derav inom human- eller veterinermedicinen samt inom kosmetiken
DE59107405D1 (de) Ein Imidazobenzodiazepin zur Behandlung von Schlafstörungen
ATE137973T1 (de) Phospholipide zur behandlung der multiplen sklerose

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee